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Abstract
Early detection and accurate estimation of the extent of coarctation of the aorta (COA) is critical 
to long-term outcome. Peak-to-peak trans-coarctation pressure gradient (PKdP) higher than 20 
mmHg is an indication for interventional/surgical repair. Patients with COA have reduced 
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proximal and distal aortic compliances. A comprehensive study investigating the effects of 
variations of proximal COA and systemic compliances on PKdP, and consequently on the COA 
severity evaluation has never been done. This study evaluates the effect of aortic compliance on 
diagnostic accuracy of PKdP. Lumped parameter modeling and in vitro experiments were 
performed for COA severities of 50%, 75% and 90% by area. Modeling and in vitro results were 
validated against retrospective clinical data of PKdP, measured in fifty-four patients with COA. 
Modeling and in vitro. PKdP increases with reduced proximal COA compliance (+36%, +38% and 
+53% for COA severities of 50%, 75% and 90%, respectively; p<0.05), but decreases with 
reduced systemic compliance (−62%, −41% and −36% for COA severities of 50%, 75% and 90%, 
respectively; p<0.01). Clinical study. PKdP has a modest correlation with COA severity (R=0.29). 
The main determinants of PKdP are COA severity, stroke volume index and systemic compliance. 
Systemic compliance was found to be as influential as COA severity in PKdP determination 
(R=0.30 vs. R=0.34). In conclusion, PKdP is highly influenced by both stroke volume index and 
arterial compliance. Low values of PKdP cannot be used to exclude the severe COA presence 
since COA severity may be masked by reduced systemic compliance and/or low flow conditions.
Keywords
Coarctation of the aorta; Arterial compliance effect; Peak to peak pressure gradient; 
Catheterization
1. Introduction
Coarctation of the aorta (COA) is the most common congenital heart defect, accounting for 
5% to 8% of all congenital heart defects, occurring in 8–11% of births annually (Roger et 
al., 2011). Despite ongoing advances in surgical techniques for COA repair the long-term 
results are not always satisfactory. The incidence of recurrence is significant (8-54%) and 
frequently requires repeat surgery (Cohen et al., 1989; Kopf et al., 1986). Surgical 
management of recurrent or residual COA is associated with some morbidity Williams et al., 
1980). The long-term prognosis after repair of COA is not entirely benign. Associated 
structural cardiovascular lesions such as mitral or aortic valve disease, ventricular septal 
defect and cerebrovascular malformations are responsible for considerable postoperative 
morbidity and mortality. Hypertension may persist even after a successful correction of 
COA (Nanton and Olley, 1976; Maia et al., 2000).
Early detection and accurate estimation of COA severity are of primary importance for 
successful long-term outcome following the initial repair (Cohen et al., 1989). In the clinical 
setting, several invasive and non-invasive modalities have been used to determine the 
severity of COA before surgery as well as to evaluate residual hypertension and/or 
obstruction after balloon dilatation or after surgery. Among them, cardiac catheterization 
with angiography and hemodynamic evaluation is considered as the gold standard for 
definitive evaluation of COA severity (Yetman et al., 1997; Maheshwari et al., 2000; 
Warnes et al., 2008). Current AHA guidelines suggest a peak-to-peak systolic trans-
coarctation pressure gradient (PKdP) > 20 mmHg as an indication for interventional/surgical 
repair (Brili et al., 1998; Vogt et al., 2005). Although many studies (Gardiner et al., 1994; 
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Xu et al., 1997; Brili et al., 1998; Vogt et al., 2005) reported that patients with COA have 
pressure overload, in the arterial circulation proximal to the COA, and reduced compliances, 
in the proximal and distal aorta, little is known about the impact of variations in the arterial 
compliance on trans-coarctation pressure gradient (Xu et al., 1997). To the best of our 
knowledge a comprehensive study investigating the effects of variations of proximal COA 
and systemic compliances on the PKdP, and consequently on the evaluation of COA severity 
has never been done in the past.
The aim of the present work was to perform such a comprehensive study using combined 
lumped parameter modeling, in vitro measurements and retrospective clinical study.
2. Methods
2.1 Lumped parameter model
We introduced a lumped parameter model (Figure 1, Table 1) that describes the interaction 
between left ventricle (LV), COA, and arterial dynamics. The validation of the model has 
already been performed using in vivo MRI data (Keshavarz-Motamed et al., 2011; 
Keshavarz-Motamed et al., 2014a). A schematic diagram of the model used in this study is 
presented in Figure 1. All parameters used in the lumped parameter model are listed in Table 
1.
2.1.1 Heart-arterial model—The ventricle is filled by a normalized physiological mitral 
flow waveform adjusted for the required stroke volume (Keshavarz-Motamed et al., 2011; 
Keshavarz-Motamed et al., 2014a). Coupling between LV pressure and volume is performed 
through a time varying elastance E(t) which is a measure of cardiac muscle stiffness.
(1)
Where PLV(t), V(t) and V0 are left ventricular time-varying pressure, time-varying volume 
and unloaded volume, respectively (Suga et al., 1973; Senzaki et al., 1996). The amplitude 
of E(t) can be normalized with respect to maximal elastance Emax, i.e., the slope of the end-
systolic pressure-volume relation, giving EN(tN)=E(t)/Emax. Time then can be normalized 
with respect to the time to reach peak elastance, TEmax (tN=t/TEmax). These normalized 
time-varying elastance curves EN(tN) have similar shapes in the normal human heart under 
various inotropic conditions or in affected human hearts irrespective of disease etiology 
(Suga et al., 1973; Senzaki et al., 1996).
(2)
This normalized curve can be described mathematically (Fourier series, polynomial 
description), and therefore, if EN(tN) is given, the relation between PLV(t) and V(t) can be 
determined for the left ventricle.
2.1.2 Modeling coarctation of the aorta—We provide here a succinct description, 
more details can be found in Keshavarz-Motamed et al. (2011). The characteristics of the 
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arterial system are of primary importance when modeling COA since only a portion of total 
flow rate will cross the COA. To take this into account in the model, two parallel branches 
are considered. The first branch simulates the flow towards the upper body, or the flow 
bypassing the COA (including aortic arch arteries and potential collaterals). A second 
branch simulates the flow crossing COA and directed towards descending aorta. This branch 
includes a resistance for the proximal descending aorta, and a time-varying resistance and an 
inductance which together represent the trans-COA net pressure gradient induced by the 
COA:
(3)
And
(4)
where , , A, ρ and Q are the energy loss coefficient of the COA, the 
effective orifice area of the COA, aortic cross sectional area downstream of the COA, the 
fluid density and the trans-COA flow rate, respectively. The energy loss coefficient is then 
expressed in terms of the aortic cross section just downstream of the COA and the effective 
orifice area of the COA (Keshavarz-Motamed et al., 2011).
2.1.3 Determining arterial compliance—Physiologically, arterial hypertension is 
determined by two factors (Safar et al., 2003): 1) a reduction in the caliber of small arteries 
or arterioles with an ensuing increase in systemic vascular resistance and mean blood 
pressure, and 2) a reduction in the arterial compliance with a resulting increase in pulse 
pressure (systolic minus diastolic blood pressure). In this study, for each degree of 
hypertension, we fitted the predicted pulse pressure to the actual pulse pressure obtained 
from in vitro study by adjusting compliances (proximal COA (Cao) and systemic (CSAC)). 
Therefore, compliance adjustment was done by a simple trial and error for each degree of 
hypertension (Keshavarz-Motamed et al., 2014a).
2.1.4 Computational algorithm—A lumped parameter model was analyzed numerically 
by creating and solving a system of ordinary differential equations in Matlab Simscape 
(MathWorks, Inc), enhanced by adding additional codes to meet demands of cardiac model 
in circuit. A Fourier series representation of an experimental normalized elastance curve for 
human adults (Senzaki et al., 1996) was used to generate a signal to be fed into the main 
program. The pressure gradient across the COA and the aortic valve was represented by an 
inductance and a variable resistor (Figure 1, Equation 3). Simulations start at the onset of 
isovolumic contraction. Left ventricle volume, V(t), is calculated using left ventricle 
pressure, PLV, and time varying elastance values (equation 1). PLV used in the beginning of 
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calculation is the initial value assumed across the variable capacitor and is automatically 
adjusted later by system of equations as solution advances. Left ventricle flow rate 
subsequently was calculated as time derivative of left ventricle volume. Matlab's ode23t 
trapezoidal rule variable-step solver was used to solve system of differential equations with 
initial time step of 0.1 milliseconds. Convergence residual criterion was set to 10−5 and 
initial voltages and currents of capacitors and inductors set to zero.
2.2 In vitro measurements
We designed and constructed a mock flow circulation model, consisted of a fluid reservoir, a 
gear pump, realistic elastic three-dimensional models of the aorta, an adjustable systemic 
arterial resistance and compliance (Figure 2). This model has been previously validated 
(Keshavarz-Motamed et al., 2012; Keshavarz-Motamed et al., 2014b). Please refer to 
Appendix A for details about in vitro setups.
2.2.1 Experimental conditions—Three different COA severities of 50%, 75% and 90% 
by area, corresponding to the diameter ratio (COA/Aorta) of 0.7, 0.5 and 0.31, respectively, 
under 4 different total flow rates of 3, 4, 5 and 6 L/min, and with a heart rate of 70 bpm were 
investigated. As patients with COA classically have upper extremity hypertension and 
reduced systemic compliance in proximal and distal segments of the COA (Gardiner et al., 
1994; Xu et al., 1997; Brili et al., 1998; Vogt et al., 2005), the impact of the arterial 
compliance on PKdP was evaluated in this study by: 1) Changing the proximal COA 
compliance (normal proximal compliance: 0.45 to 0.5 mL/mmHg; low proximal 
compliance: 0.25 to 0.45 mL/mmHg; very low proximal compliance: 0.1 to 0.25 mL/
mmHg); 2) Changing the systemic compliance (normal systemic compliance: 1.9 to 2 mL/
mmHg; low systemic compliance: 1.4 to 1.9 mL/mmHg; very low systemic compliance: 
0.85 to 1.4 mL/mmHg). Proximal COA compliance was reduced, in vitro, using custom-
made fixtures designed to fit the region. These fixtures locally reduced the elasticity of the 
phantom without introducing any geometrical deformation that may have an impact on the 
fluid flow. Using these fixtures, experiments with different levels of rigidity of the proximal 
COA were performed. The changes in the systemic arterial compliance were obtained by 
modifying the pressure conditions in the systemic compliance module using a column of 
water (Figure 2).
2.3 Clinical data measurements
2.3.1 Ethics statement—Patients with COA, requiring diagnostic or interventional 
cardiac catheterization, were considered for this study. Measurements were performed 
according to the American College of Cardiology & American Heart Association guidelines 
(Tracy et al., 2000; Pepine et al., 1991). The protocol was reviewed and approved by the 
Ethics Committee of Milad-Noor Hospital affiliated Tehran University of Medical Sciences, 
Tehran, Iran. All patients provided written informed consent under the supervision of the 
Institutional Review Board.
2.3.2 Study population—Fifty-nine patients with COA, ranged in age from 4 to 26 years, 
referred to Milad-Noor Hospital between April 2010 and December 2012, were included in 
this study. Associated cardiovascular lesions included bicuspid aortic valve (eighteen 
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patients), mild and moderate tricuspid aortic valve stenosis (eight patients), small patent 
ductus arteriosus (four patients), small ventricular septal defect (one patient) and mild mitral 
stenosis (two patients).
2.3.3 Measurements—A diagnostic catheterization was performed to determine the exact 
morphology and the pressure gradient of the COA in all patients. Angiography was 
performed in lateral and anteroposterior or left anterior oblique projections. Measurements 
of the aorta were made and averaged at five different sites: ascending aorta, isthmus 
proximal coarctation, coarcted region, descending aorta distal to the coarctation as well as at 
the level of the diaphragm. For the assessment of COA, the pullback PKdP was obtained 
across the COA site. Pressure drop estimation was unsuccessful in five neonates with 
coarctation and a patent ductus arteriosus and interrupted aortic arch, resulting in a total of 
fifty-four successful studies.
2.3.4 Systemic arterial compliance—Systemic arterial compliance (CSAC) was 
determined as (Keshavarz-Motamed et al., 2014a):
(5)
where SVi, PP are stroke volume indexed by the body surface area and brachial pulse 
pressure, respectively. Stroke volume was measured using Doppler echocardiography either 
at catheterization or 24 hours before catheterization with a commercially available 
echocardiography machine (Vivid 3, GE Ultrasound, Horten, Norway).
2.4 Statistical analysis
Results were expressed as mean ± SD. In the multivariate analysis, we included all variables 
with p<0.05 in the univariate analysis as the criterion for entry of the variable into the 
model. Standardized regression coefficients were presented as mean ± standard error (βeta 
coeff ± SE). Statistical analysis was performed with SPSS 17 (SPSS, Chicago, IL).
3. Results
3.1 In vitro measurements and lumped parameter modeling
Figure 3 represents a sample of the in vitro data for a COA with a 90% reduction in area and 
for a total flow rate of 6 L/min. It can be noticed that as a result of changing proximal COA 
compliance, the PKdP substantially increases from 30 mmHg to 46 mmHg (Figure 3a); 
while, interestingly, changes in systemic compliance have an opposite effect leading to a 
decrease in PKdP from 30 mmHg to 19 mmHg.
3.1.1 Effect of reduced proximal coa compliance on PKdP—Results from both in 
vitro measurements and lumped parameter model (Figure 4a) demonstrated that PKdP is 
greatly affected by the variation of the proximal COA compliance. For all COA severities, 
PKdP increases significantly, when proximal COA compliance was reduced from 0.5 to 0.1 
mL/mmHg. In vitro, PKdP increased by +36% (9 to 12.3 mmHg) for 50% COA, by +38% 
(18 to 25 mmHg) for 75% COA and by +53% (30 to 46 mmHg) for 90% COA. PKdP with 
reduced proximal COA compliance was significantly higher than with normal COA 
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compliance for all COA severities (Figure 4b, p < 0.05 for 50% COA; p < 0.01 for 75% 
COA and 90% COA). In all conditions, lumped parameter model predictions are consistent 
with in vitro findings. The slopes of the lines fitted to the in vitro and model results, are 
within the range of 3% to 7% (Figure 4a).
3.1.2 Effect of reduced systemic compliance on PKdP—Both in vitro 
measurements and the lumped-parameter modeling show that the effect of the systemic 
compliance on the PKdP is the inverse of that of the proximal COA compliance: reduction in 
the systemic compliance increases the PKdP (Figure 5a). In this case, for all COA severities, 
PKdP decreased significantly, when systemic compliance was reduced from 2.0 to 0.85 mL/
mmHg. In vitro, PKdP decreased by 62% (9 to 3.4 mmHg) for 50% COA, by 41% (18 to 
10.6 mmHg) for 75% COA and by 36% (30 to 19 mmHg) for 90% COA. PKdP with 
reduced systemic compliance was significantly lower than with normal compliance for all 
COA severities (Figure 5b, p < 0.01). In all conditions, lumped parameter model predictions 
are consistent with in vitro findings. The slopes of the lines fitted to the in vitro and model 
results, are within the range of 3.5% to 8% (Figure 5a).
Finally, note that, for simplicity, only results at the flow rate of 6 L/min and symmetric 
COAs are displayed, similar observations were also made with the other three flow rates (3, 
4 and 5 L/min) and with asymmetric COAs with the same severities.
3.2 Clinical study
Baseline characteristics of the patients are listed in Table 2, including mean blood pressure 
of 100 ± 10.25 mmHg, mean COA diameter of 14 ± 1.6 mm and mean COA severity of 70 ± 
9.73%, corresponding to a mean diameter ratio (COA/Aorta) of 0.59 ± 0.87. According to 
these data, there was a modest correlation between PKdP and COA severity (R = 0.29, 
Figure 6a), SVi (R = 0.49, Figure 6b) and CSAC (R = 0.36, Figure 6c). Nevertheless, 
multivariate analysis showed that COA severity, SVi and CSAC were the main independent 
determinants of PKdP. These variables together explained all the variance of PKdP (Table 3).
4. Discussion
The most important predictor of successful long-term outcome in patients with COA is age 
at time of initial repair (Cohen et al., 1989). As a consequence, early detection and accurate 
estimation of COA severity is of primary importance. Cardiac catheterization with 
significant PKdP across the coarcted segment (PKdP > 20 mmHg) is an important indication 
of significant COA (Maheshwari et al., 2000; Ralph-Edwards et al., 1995; Beekman et al., 
1981). Many studies reported that patients with COA have reduced compliances, in the 
proximal and distal aorta (e.g., Gardiner et al., 1994; Xu et al., 1997; Brili et al., 1998; Vogt 
et al., 2005). However little to no literature is treating about the impact of variations in the 
arterial compliance on trans-coarctation pressure gradient, and consequently on the 
evaluation of COA severity (Xu et al., 1997; Seifert et al., 1999). The main findings of this 
study are the followings: 1) reduction in proximal aortic compliance increases PKdP; 2) 
reduction in systemic compliance deceases PKdP; 3) the main determinants of the variations 
in PKdP are SVi, COA severity and systemic compliance; 4) systemic compliance is as 
important as COA severity in the determination of PKdP.
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4.1 Patients with COA and reduced proximal COA compliance
Patients with COA usually have upper extremity hypertension and are characterized by 
reduced compliance in both proximal and distal of COA (Gardiner et al., 1994; Xu et al., 
1997; Brili et al., 1998; Vogt et al., 2005). A widespread structural alteration of the aortic 
wall in patients with COA may be responsible for these abnormalities (Gardiner et al., 
1994). However, proximal COA was stiffer than distal aorta in patients with COA (Xu et al., 
1997). The results of this study show that reduced proximal COA compliance interacts with 
COA and amplified PKdP. This could in part explain why some patients who have had a 
good repair of COA may have residual upper body hypertension at rest or with exercise 
despite having little evidence of significant recoarctation (Nanton and Olley, 1976; Maia et 
al., 2000; Gunthard et al., 1996).
4.2 Patients with COA and reduced systemic compliance
Patients with COA have higher incidence of systemic hypertension (up to 68%) even after 
successful repair of the COA (Clarkson et al., 1983; Maia et al., 2000). Systemic 
hypertension is associated with elevated systemic resistance and reduced systemic 
compliance. The results of this study show that PKdP is significantly affected by the 
variation in systemic compliance: PKdP reduced by a decrease in systemic compliance. 
Furthermore, in the clinical data set, PKdP correlated significantly with systemic compliance 
and was found to be as important as COA severity in determination of PKdP variations.
4.3 Potential role of pressure-wave reflections on PKdP in patients with COA
Effects of proximal COA and systemic arterial compliances on the variations of PKdP can be 
partially explained by pressure-wave reflections in the aorta in the presence of the COA. 
COA causes a significant mismatch in terms of the dispensability between the ascending 
aorta and the descending aorta. COA also represents a localized site for the enhancement of 
pressure-wave reflections towards the ascending aorta but also towards the lower body 
(O'Rourke and Cartmill, 1971; Van den wijngaard et al., 2009). As a consequence, changes 
in the compliances upstream (proximal aorta) and downstream (systemic arterial 
compliance) of the COA further amplify pressure wave reflections irrespective of COA 
severity (schematic diagram in Figure 7). A reduction in the proximal aortic compliance 
leads to an early return of the reflected pressure waves from the COA into the ascending 
aorta. This leads to an increase in the peak-aortic systolic pressure (O'Rourke and Cartmill, 
1971). As a consequence, the PKdP is increased without any changes in the COA severity 
(Figure 7a). In contrast, a lower systemic compliance leads to an early return of the reflected 
pressure waves from the lower body towards the COA region. Thus, with no change in the 
COA severity, the PKdP falls as peak systolic pressure downstream of the COA rises (Figure 
7b).
5. Conclusion
PKdP recordings must be used with caution in patients with reduced proximal COA 
compliance and /or systemic compliance. In particular, low recorded values of PKdP should 
not be used to exclude severe COA in patients since this may result from reduced flow rate 
and/or reduced systemic arterial compliance. The aforementioned results suggest that COA 
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is in fact a much more complex disease than previously thought and that limiting its 
evaluation to the determination of the PKdP is probably a gross oversimplification that may 
lead to erroneous conclusions.
6. Limitations of the study
The lumped parameter model presented in this study is capable of modeling different COA 
configurations and anatomical abnormalities of the aortic arch after successful repair of 
COA (Ou et al., 2004) through adjusting compliances (proximal COA (Cao) and systemic 
arteries (CSAC)) as well as resistances (aortic (Rao) and systemic arteries (RSA)) using the 
method introduced in Keshavarz-Motamed et al. (2014a). However, investigation of various 
COA configurations and anatomical abnormalities of the aortic arch has not been covered in 
this study. Also, patients with severe COA are usually hypertensive and might exhibit 
physiological changes such as variation in the heart rate. These physiological changes are 
out of the scope of this study. Nevertheless, this study did reveal that PKdP is highly 
influenced by the stroke volume index and arterial compliance. Future studies can 
investigate the above mentioned parameters in vitro and in silico.
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Fig. 1. 
Schematic diagram of the lumped parameter model. (a) electrical representation, (b) 
anatomical representation. Abbreviations are similar as in Table 1
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Fig. 2. 
Schematic diagram of the in vitro flow model. PKdP: peak-to-peak pressure gradient
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Fig. 3. 
(a) Example of variations in in vitro PKdP due to changes in proximal COA compliance; (b) 
Example of variations in in vitro PKdP due to changes in systemic compliance. PKdP: peak-
to-peak pressure gradient. Total flow rate: 6 L/min; COA severity: 90%
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Fig. 4. 
(a) in vitro and simulated PKdP variations with proximal COA compliance for different 
COA severities; (b) in vitro PKdP variations with proximal COA compliance (*: p<0.01 
compared with normal proximal COA compliance; †: p<0.05 compared with normal 
proximal COA compliance). PKdP: peak-to-peak pressure gradient. Total flow rate: 6 L/min
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Fig. 5. 
(a) in vitro and simulated PKdP variations with systemic compliance for different COA 
severities; (b) in vitro and simulated PKdP variations with systemic compliance (*: p<0.01 
compared with normal systemic arterial compliance). PKdP: peak-to-peak pressure gradient. 
Total flow rate: 6 L/min
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Fig. 6. 
Clinical variations of (a) PKdP with COA severity; (b) PKdP with stroke volume index 
(SVi); (c) PKdP with systemic arterial compliance (CSAC). PKdP: peak-to-peak pressure 
gradient
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Fig. 7. 
Schematic representation of (a) variations in PKdP due to changes in proximal COA 
compliance changes; (b) variations in PKdP due to changes in systemic compliance. PKdP: 
peak-to-peak pressure gradient
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Table 1
Cardiovascular parameters used in the lumped parameter modeling to simulate coarctation of the aorta
Description Abbreviation Value Maximum error*
COA and valve parameters
Effective orifice area EOA From COA and aortic valve data
Energy loss coefficient ELCo (EOA)A
A − EOA  From COA and aortic valve data
Variable resistance Rcoa & Rav ρ
2EL Co
2 Q From COA and aortic valve data
Inductance Lcoa & Lav 2πρ
EL Co
 From COA and aortic valve data
Systematic circulation parameters
Aortic resistance Rao 0.05 mmHg.s.mL−1 0.31%
Aortic compliance Cao Initial value: 0.5 mL/mmHg Adjust for each 
degree of hypertension (Proximal COA 
compliance)
0.41%
Systemic vein resistance RSV 0.05 mmHg.s.mL−1 0.26%
Systemic arteries and veins compliance CSAC Initial value: 2 mL/mmHg Adjust for each 
degree of hypertension (Systemic compliance)
0.91%
systemic arteries resistance (including arteries, 
arterioles and capillaries)
RSA 0.8 mmHg.s.mL−1 1.13%
Upper body resistance Rub Adjusted to have 15% of total flow rate in 
healthy case (McDonald, 1974)
0.55%
Proximal descending aorta resistance Rpda 0.05 mmHg·s·mL−1 0.48%
Output condition
Central venous pressure PCVO 4 mmHg
Input condition
Mitral valve mean flow rate Qmv
Other
Constant blood density 1050 kg/m3
Heart rate HR 70 beats/min
Duration of cardiac cycle T 0.857 s
*
Maximum error in computed PKdP from sensitivity analysis in response to independent variation (±30%) in each parameter.
J Biomech. Author manuscript; available in PMC 2015 December 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Keshavarz-Motamed et al. Page 20
Table 2
Baseline patient characteristics
COA Patients (n=54, mean ± SD)
Patient description
Mean age, years 13.1 ± 3.3 (4-26)
Gender
Male, n 33
Female, n 21
Mean weight, kg 39.2 ± 18.4 (13-94)
Stroke volume index (SVi)(mL.m−2) 43 ± 8.47 (25.97-66)
Arterial hemodynamics
Systemic arterial compliance (CSAC) (mL.mmHg−1) 1 ± 0.26 (0.31-1.61)
Systolic arterial pressure (mmHg) 142 ± 18 (107-180)
Diastolic arterial pressure (mmHg) 79 ± 9.57 (56-100)
Coarctation description
COA length, mm 25 ± 6.2 (10-35)
COA diameter, mm 14 ± 1.6 (10.3-18.2)
COA severity, % 70 ± 9.73 (44-85)
Diameter ratio (COA/Aorta) 0.59 ± 0.87 (0.38-0.75)
Associated cardiovascular lesions
Bicuspid aortic valve (BAV) 18
Tricuspid aortic valve stenosis (AS)
Moderate, n 7
severe, n 1
Small patent ductus arteriosus 4
Small ventricular septal defect 1
Mild mitral stenosis 2
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Table 3
Univariate and multivariate analyses for peak-to-peak pressure gradient, PKdP
PKdP Based on clinical data
Univariate Analysis Multivariate Analysis
*Std βeta coefficient ± SE p-value R *Std βeta coefficient ± SE p-value R
COA severity (%) 0.29 ± 0.11 0.04 0.29 0.34 ± 0.1 0.01 0.34
SVi (mL/m2) 0.49 ± 0.07 < 0.001 0.49 0.30 ± 0.09 0.04 0.3
CSAC (mL/mmHg) 0.36 ± 3.71 < 0.01 0.36 0.30 ± 0.41 0.04 0.3
Bicuspid aortic valve 0.11 ± 7.89 0.45 0.11 - - -
p<0.05 in the Univariate analysis is the criterion for entry of the variable into the Multivariate analysis
The total R of the multivariable model was 0.94
*Std βeta coeff ± SE: Standardized βeta coefficient and standard error
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